| Legal Statement -Terms of Use Contact Webmaster Copyright 2009. DeoBioSciences, Inc. All rights reserved. |
Site Word Search
Real Cancer Drug Breakthrough is Astronomical
Prices In the wake of the FDA’s decision start the process to
revoke Avastin’s approval in breast cancer last week, patients are
puzzled and angry over how a drug once touted as a breakthrough
now can be branded as ineffective. The controversy illustrates....
Prices In the wake of the FDA’s decision start the process to
revoke Avastin’s approval in breast cancer last week, patients are
puzzled and angry over how a drug once touted as a breakthrough
now can be branded as ineffective. The controversy illustrates....
Cornell University has once again been ranked
the No. 1 vet program in the nation...
Cornell University's College of Veterinary Medicine has once again
been ranked as the No. 1 veterinary program in the nation in U.S.
News and World Report's 2011 edition of America's Best Graduate
Schools. More>>>>
the No. 1 vet program in the nation...
Cornell University's College of Veterinary Medicine has once again
been ranked as the No. 1 veterinary program in the nation in U.S.
News and World Report's 2011 edition of America's Best Graduate
Schools. More>>>>
Introduction to Microcap Investing: The
Explosive Power of a Catalyst Generally when Warren
Buffett speaks most people pay attention, that does not appear to be
the case in regard to microcap investing. In reality, small companies
are not riskier investments than their larger brethren per se, as long
as they possess a margin of safety.
Explosive Power of a Catalyst Generally when Warren
Buffett speaks most people pay attention, that does not appear to be
the case in regard to microcap investing. In reality, small companies
are not riskier investments than their larger brethren per se, as long
as they possess a margin of safety.
Study Provides Further Insight Into Breast
Cancer Disparities. In their ongoing quest to better understand
racial disparities in breast cancer, researchers analyzed tissue from
White) who are participants in the Carolina Breast Cancer Study
(CBCS). More>>>>
Cancer Disparities. In their ongoing quest to better understand
racial disparities in breast cancer, researchers analyzed tissue from
White) who are participants in the Carolina Breast Cancer Study
(CBCS). More>>>>
The US Food and Drug Administration (FDA) has begun its process to
remove the breast cancer indication from bevacizumab’s (Avastin,
Genentech) label. Its decision to move forward is based on a
recommendation by it advisory committee composed mainly of
oncology. More>>>>
remove the breast cancer indication from bevacizumab’s (Avastin,
Genentech) label. Its decision to move forward is based on a
recommendation by it advisory committee composed mainly of
oncology. More>>>>
 | |  | |  | |  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |